2010
DOI: 10.1016/j.ejmg.2010.02.008
|View full text |Cite
|
Sign up to set email alerts
|

Delineation of a recognisable phenotype of interstitial deletion 3 (q22.3q25.1) in a case with previously unreported truncus arteriosus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2010
2010
2018
2018

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 8 publications
0
8
0
Order By: Relevance
“…In humans, a rare interstitial deletion in the long arm of chromosome 3 (3q22-q23 microdeletion) causes ptosis, microphthalmia, developmental delays and brain malformation, among other phenotypes (Al-Awadi et al, 1986;Alvarado et al, 1987;Martsolf and Ray, 1983;Rea et al, 2010;Zahanova et al, 2012). These symptoms bear a strong resemblance to the phenotypes observed in Rbx2cKO-Nes mice.…”
Section: Rbx2 and Human Chromosome 3 Deletionsmentioning
confidence: 99%
“…In humans, a rare interstitial deletion in the long arm of chromosome 3 (3q22-q23 microdeletion) causes ptosis, microphthalmia, developmental delays and brain malformation, among other phenotypes (Al-Awadi et al, 1986;Alvarado et al, 1987;Martsolf and Ray, 1983;Rea et al, 2010;Zahanova et al, 2012). These symptoms bear a strong resemblance to the phenotypes observed in Rbx2cKO-Nes mice.…”
Section: Rbx2 and Human Chromosome 3 Deletionsmentioning
confidence: 99%
“…In Figure these seven patients with clinical diagnosis of WS and additional cases of 3q deletion, without a clinical diagnosis of WS are shown along with our case to aid in narrowing the WS critical region [Rea et al, ; Lim et al, ; Ramieri et al, ; Weber et al, ]. Patient 12 has a deletion that distally overlaps with ours, but apparently no clinical diagnosis of WS [Lim et al, ].…”
Section: Discussionmentioning
confidence: 72%
“…Two genes are present in this region, MBNL1 and TMEM14E. Pt1: Tohyama et al []; Pt2: Willemsen et al [], case1; Pt3: Willemsen et al [], case2; Pt4: Willemsen et al [], case3; Ko et al []; Pt5: Moortgat et al []; Pt6: Ferraris et al [], case1; Pt7: Ferraris et al [], case2; Pt8: present case; Pt9: Rea et al []; Pt10:Weber et al []; Pt11: Ramieri et al []; Pt12: Lim et al []. [Color figure can be viewed at wileyonlinelibrary.com].…”
Section: Discussionmentioning
confidence: 99%
“…Remarkably, in Patient 9 array CGH showed that the FOXL2 gene was not deleted, though this patient had the classical phenotype of BPES. It was suggested that this might be the result of disruption of regulatory elements regulating FOXL2 expression [Rea et al, 2010]. Patients 15–19 are the only five previously reported patients with an overlapping deletion who do not show the clinical phenotype of BPES and, thus, are the most suitable candidates for phenotype–genotype comparison with the present three patients, though comparison of the phenotypes is also hampered due to limited description of clinical features of Patients 15–19.…”
Section: Discussionmentioning
confidence: 99%
“…Most patients with a deletion in this region have blepharophimosis–ptosis–epicanthus inversus syndrome (BPES; OMIM # 110100) due to deletion of the gene forkhead transcription factor FOXL2 ( FOXL2 ; OMIM*605597) located in 3q22.3 [Crisponi et al, 2001; De Baere et al, 2001; De Baere et al, 2003]. Patients with interstitial deletions of the long arm of chromosome 3 also have ID, microcephaly, pre‐ and postnatal growth retardation, congenital heart defects, and various skeletal anomalies [Williamson et al, 1981; Franceschini et al, 1983; Martsolf and Ray, 1983; Al‐Awadi et al, 1986; Alvarado et al, 1987; Robin et al, 1993; Wolstenholme et al, 1994; Warburg et al, 1995; Chandler et al, 1997; Slavotinek et al, 1997; Costa et al, 1998; Sudha et al, 2001; Engelen et al, 2002; de Ru et al, 2005; Rea et al, 2010].…”
Section: Introductionmentioning
confidence: 99%